The human progenitor cell antigen (CD34) is localized on endothelial cells, dermal dendritic cells, and perifollicular cells in formalin-fixed normal skin, and on proliferating endothelial cells and stromal spindle-shaped cells in Kaposi's sarcoma
Pfizer has entered the space through the acquisition of Metsera, and Roche recently reported positive Phase II data for its dual GLP-1/GIP receptor agonist in January 2026
Apr 2021;21(4):306
This consistency supports stable medication levels in your system, which is key to managing hunger and making progress
Understanding GLP-1 Agonists: Key Insights for Payers By: Emily Crisano PharmD, RPh , and Jason Peterson, RPh , RPh The rapid adoption of GLP-1 treatments underscores their significance in modern therapeutic practices, making it imperative for payers, healthcare providers and consumers to stay informed about their evolving uses and market dynamics
Richman, S